IDEX (IEX) Stock Forecast & Price Target

IDEX is benefiting from stronger organic growth across all three segments, led by HST’s exposure to data centers, semiconductors, space/defense, and life sciences, where 2Q26 orders rose 28% year over year and HST orders jumped 47%. The company’s 2026 outlook now implies 5%-6% organic sales growth and adjusted EPS of $8.70-$8.85, supported by productivity gains, IEEPA tariff refund benefits, and improving margins, while free cash flow converted at 103% of net income and net leverage stayed low at 1.3x. Its positive view is further reinforced by a high-quality portfolio, visible backlog through the end of 2026, a $1.1B+ liquidity cushion for accretive buybacks and bolt-on M&A, and growing momentum in high-margin water and industrial end markets.

IDEX is facing a negative setup because its short-cycle businesses leave limited visibility, making demand choppiness, tariff-driven pressure, and inventory resets harder to absorb. Although 2Q26 adjusted cash EPS guidance of $2.07-$2.12 and organic sales growth of 3%-4% are solid, adjusted EBITDA margins of 26.5%-27.0% imply a 70 bps year-over-year decline at the midpoint due to tariff timing and higher corporate costs. With shares at 22.4x 2027 P/E and near peers, the valuation looks unexciting given risks from municipal funding volatility, FX, and execution on M&A and growth platforms.